{"Exaggerate": "The claim suggests that the COVID-19 vaccine was distributed in Nebraska before the FDA even approved it. However, the expert's verdict provides evidence that contradicts this claim, indicating that the vaccine distribution did not occur before FDA approval.", "Contradict fact": "The claim contradicts the fact that the FDA announced the approval of the Pfizer-BioNTech vaccine on December 11, while the Nebraska Department of Health and Human Services announced the arrival of the vaccine on December 14.", "Lack enough support": "The claim lacks sufficient evidence or support to prove that the vaccine was distributed in Nebraska before FDA approval. The expert's verdict provides multiple sources and statements that indicate the opposite.", "Problematic assumption": "The claim assumes that the vaccine was distributed before FDA approval based on the timing of its arrival in Nebraska. However, the expert's verdict highlights the proper process of vaccine distribution, which starts 24 hours after FDA authorization.", "Exist alternative explanation": "The expert's verdict provides alternative explanations for the claim, such as the timing of vaccine packaging and the emphasis on quality assurance before distribution."}